http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2339475-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_315ae544538aaeac6d1f4eed6754e4bb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-80
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N37-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N47-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N33-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-653
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-707
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-80
filingDate 1999-08-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e97b2e38e86417b7d268e52d72f164cb
publicationDate 2000-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CA-2339475-A1
titleOfInvention Combination of two or more active ingredients using microencapsulated formulations
abstract Provided is a method of encapsulating clomazone and a second biological agent comprising: (a) mixing (i) an aqueous phase, (ii) an emulsifier and (iii) a water-immiscible phase containing clomazone, the second biological agent, and at least one first polyfunctional compound; (b) forming a dispersion of water-immiscible droplets throughout the aqueous phase; and (c) adding at least one second polyfunctional compound into the dispersion and reacting the second polyfunctional compound(s) with the first polyfunctional compound(s) to form a polymer shell around the water-immiscible droplets. Further provided is a method of preparing an agricultural composition comprising encapsulated clomazone and a second biological agent, the method comprising: (a) providing a suspension of clomazone capsules comprising solutes, diluents or carriers; (b) providing a composition of suspended particles of the second biological agent; (c) adjusting solutes, diluents or carriers in the particle suspension so that the osmolarity of the particle suspension is sufficiently like that of the capsule suspension so that the capsules are not disrupted when the suspensions of steps (a) and (b) are mixed; and (d) mixing the suspensions of steps (a) and (b).
priorityDate 1998-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452207757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419593639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413743334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID39722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4933
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419531489
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID38479
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID30479
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520438
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419544483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54778
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410506103
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID105034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21584854
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421074684
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86369
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635

Total number of triples: 43.